FDA
-
-
-
-
-
-
-
Mind Medicine (MNMD) Receives FDA Type C Meeting Response for Project Lucy Phase 2b Clinical Trial
-
-
-
-
-
-
-
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
-
-
-
323,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

